PDB Short entry for 1VJB HEADER TRANSCRIPTION 03-FEB-04 1VJB TITLE CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED TITLE 2 RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXYTAMOXIFEN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN-RELATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ESTROGEN RECEPTOR-RELATED PROTEIN 3,NUCLEAR RECEPTOR COMPND 5 SUBFAMILY 3 GROUP B MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: ESRRG, ERR3, KIAA0832, NR3B3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET-15B KEYWDS LIGAND-BINDING DOMAIN, ANTAGONIST COMPLEX, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR H.GRESCHIK,R.FLAIG,J.P.RENAUD,D.MORAS REVDAT 5 23-AUG-23 1VJB 1 REMARK REVDAT 4 13-JUN-18 1VJB 1 COMPND SOURCE SEQADV REVDAT 3 24-FEB-09 1VJB 1 VERSN REVDAT 2 10-AUG-04 1VJB 1 JRNL REVDAT 1 08-JUN-04 1VJB 0 JRNL AUTH H.GRESCHIK,R.FLAIG,J.P.RENAUD,D.MORAS JRNL TITL STRUCTURAL BASIS FOR THE DEACTIVATION OF THE JRNL TITL 2 ESTROGEN-RELATED RECEPTOR {GAMMA} BY DIETHYLSTILBESTROL OR JRNL TITL 3 4-HYDROXYTAMOXIFEN AND DETERMINANTS OF SELECTIVITY. JRNL REF J.BIOL.CHEM. V. 279 33639 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15161930 JRNL DOI 10.1074/JBC.M402195200 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1212173.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 8063 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.256 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 372 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.014 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1265 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 61 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.046 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3188 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 15.31000 REMARK 3 B22 (A**2) : 15.31000 REMARK 3 B33 (A**2) : -30.62000 REMARK 3 B12 (A**2) : 7.46000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.47 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 25.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.55 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.320 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.82 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.980 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.26 REMARK 3 BSOL : 35.11 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 4OHT.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : 4OHT.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1VJB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-FEB-04. REMARK 100 THE DEPOSITION ID IS D_1000021513. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9804 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8116 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 30.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.22900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1KV6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 96.51867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 48.25933 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 48.25933 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 96.51867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 208 REMARK 465 GLY A 209 REMARK 465 SER A 210 REMARK 465 SER A 211 REMARK 465 HIS A 212 REMARK 465 HIS A 213 REMARK 465 HIS A 214 REMARK 465 HIS A 215 REMARK 465 HIS A 216 REMARK 465 HIS A 217 REMARK 465 SER A 218 REMARK 465 SER A 219 REMARK 465 GLY A 220 REMARK 465 LEU A 221 REMARK 465 VAL A 222 REMARK 465 PRO A 223 REMARK 465 ARG A 224 REMARK 465 GLY A 225 REMARK 465 SER A 226 REMARK 465 HIS A 227 REMARK 465 MET A 228 REMARK 465 PRO A 229 REMARK 465 ALA A 230 REMARK 465 LYS A 231 REMARK 465 LYS A 232 REMARK 465 PRO A 233 REMARK 465 GLY A 442 REMARK 465 LYS A 443 REMARK 465 VAL A 444 REMARK 465 PRO A 445 REMARK 465 MET A 446 REMARK 465 HIS A 447 REMARK 465 LYS A 448 REMARK 465 LEU A 449 REMARK 465 PHE A 450 REMARK 465 LEU A 451 REMARK 465 GLU A 452 REMARK 465 MET A 453 REMARK 465 LEU A 454 REMARK 465 GLU A 455 REMARK 465 ALA A 456 REMARK 465 LYS A 457 REMARK 465 VAL A 458 REMARK 465 MET B 208 REMARK 465 GLY B 209 REMARK 465 SER B 210 REMARK 465 SER B 211 REMARK 465 HIS B 212 REMARK 465 HIS B 213 REMARK 465 HIS B 214 REMARK 465 HIS B 215 REMARK 465 HIS B 216 REMARK 465 HIS B 217 REMARK 465 SER B 218 REMARK 465 SER B 219 REMARK 465 GLY B 220 REMARK 465 LEU B 221 REMARK 465 VAL B 222 REMARK 465 PRO B 223 REMARK 465 ARG B 224 REMARK 465 GLY B 225 REMARK 465 SER B 226 REMARK 465 HIS B 227 REMARK 465 MET B 228 REMARK 465 PRO B 229 REMARK 465 ALA B 230 REMARK 465 LYS B 231 REMARK 465 LYS B 232 REMARK 465 LYS B 443 REMARK 465 VAL B 444 REMARK 465 PRO B 445 REMARK 465 MET B 446 REMARK 465 HIS B 447 REMARK 465 LYS B 448 REMARK 465 LEU B 449 REMARK 465 PHE B 450 REMARK 465 LEU B 451 REMARK 465 GLU B 452 REMARK 465 MET B 453 REMARK 465 LEU B 454 REMARK 465 GLU B 455 REMARK 465 ALA B 456 REMARK 465 LYS B 457 REMARK 465 VAL B 458 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 236 CG CD CE NZ REMARK 470 GLU A 247 CG CD OE1 OE2 REMARK 470 PRO A 255 CG CD REMARK 470 ASP A 270 CG OD1 OD2 REMARK 470 GLU A 321 CG CD OE1 OE2 REMARK 470 LYS A 338 CG CD CE NZ REMARK 470 LEU A 339 CG CD1 CD2 REMARK 470 LYS A 355 CG CD CE NZ REMARK 470 LYS A 360 CG CD CE NZ REMARK 470 LYS A 390 CG CD CE NZ REMARK 470 LYS A 430 CG CD CE NZ REMARK 470 TYR A 436 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 439 CG CD CE NZ REMARK 470 LEU A 440 CG CD1 CD2 REMARK 470 GLU A 441 CB CG CD OE1 OE2 REMARK 470 PRO B 233 CB CG CD REMARK 470 TYR B 234 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR B 234 OH REMARK 470 ASN B 235 CG OD1 ND2 REMARK 470 LEU B 241 CG CD1 CD2 REMARK 470 ILE B 249 CG1 CG2 CD1 REMARK 470 PRO B 258 CB CG CD REMARK 470 ASP B 259 CG OD1 OD2 REMARK 470 LEU B 294 CG CD1 CD2 REMARK 470 LEU B 339 CG CD1 CD2 REMARK 470 LEU B 350 CG CD1 CD2 REMARK 470 LYS B 355 CG CD CE NZ REMARK 470 LYS B 357 CG CD CE NZ REMARK 470 LYS B 360 CG CD CE NZ REMARK 470 LYS B 363 CG CD CE NZ REMARK 470 LYS B 390 CG CD CE NZ REMARK 470 LYS B 430 CG CD CE NZ REMARK 470 TYR B 436 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 439 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 253 C - N - CA ANGL. DEV. = 11.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 245 109.50 -42.47 REMARK 500 PRO A 246 160.89 -45.88 REMARK 500 MET A 252 76.29 49.78 REMARK 500 PRO A 253 63.10 -58.54 REMARK 500 ASP A 254 116.52 -14.65 REMARK 500 PRO A 255 67.26 -65.67 REMARK 500 THR A 256 -76.71 -132.33 REMARK 500 SER A 319 11.81 -59.85 REMARK 500 ASP A 322 19.15 51.66 REMARK 500 ALA A 327 147.41 -170.44 REMARK 500 LYS A 360 71.01 37.77 REMARK 500 HIS A 381 54.54 -112.45 REMARK 500 ASN A 437 0.46 -61.37 REMARK 500 ILE A 438 -92.09 -41.99 REMARK 500 TYR B 234 105.74 163.09 REMARK 500 ALA B 244 -8.43 -59.70 REMARK 500 MET B 252 59.63 77.53 REMARK 500 ALA B 283 -37.11 -39.89 REMARK 500 PRO B 287 129.39 -37.01 REMARK 500 ASP B 322 -2.25 72.01 REMARK 500 HIS B 381 34.14 -94.41 REMARK 500 ASP B 384 74.23 -113.57 REMARK 500 PRO B 411 0.52 -63.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHT A 100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHT B 200 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KV6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ESTROGEN-RELATED RECEPTOR GAMMA LIGAND- REMARK 900 BINDING DOMAIN (APO FORM) COMPLEXED WITH A STEROID RECEPTOR REMARK 900 COACTIVATOR 1 PEPTIDE DBREF 1VJB A 229 458 UNP P62509 ERR3_MOUSE 229 458 DBREF 1VJB B 229 458 UNP P62509 ERR3_MOUSE 229 458 SEQADV 1VJB MET A 208 UNP P62509 INITIATING METHIONINE SEQADV 1VJB GLY A 209 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER A 210 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER A 211 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS A 212 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS A 213 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS A 214 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS A 215 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS A 216 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS A 217 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER A 218 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER A 219 UNP P62509 EXPRESSION TAG SEQADV 1VJB GLY A 220 UNP P62509 EXPRESSION TAG SEQADV 1VJB LEU A 221 UNP P62509 EXPRESSION TAG SEQADV 1VJB VAL A 222 UNP P62509 EXPRESSION TAG SEQADV 1VJB PRO A 223 UNP P62509 EXPRESSION TAG SEQADV 1VJB ARG A 224 UNP P62509 EXPRESSION TAG SEQADV 1VJB GLY A 225 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER A 226 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS A 227 UNP P62509 EXPRESSION TAG SEQADV 1VJB MET A 228 UNP P62509 EXPRESSION TAG SEQADV 1VJB MET B 208 UNP P62509 INITIATING METHIONINE SEQADV 1VJB GLY B 209 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER B 210 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER B 211 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS B 212 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS B 213 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS B 214 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS B 215 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS B 216 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS B 217 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER B 218 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER B 219 UNP P62509 EXPRESSION TAG SEQADV 1VJB GLY B 220 UNP P62509 EXPRESSION TAG SEQADV 1VJB LEU B 221 UNP P62509 EXPRESSION TAG SEQADV 1VJB VAL B 222 UNP P62509 EXPRESSION TAG SEQADV 1VJB PRO B 223 UNP P62509 EXPRESSION TAG SEQADV 1VJB ARG B 224 UNP P62509 EXPRESSION TAG SEQADV 1VJB GLY B 225 UNP P62509 EXPRESSION TAG SEQADV 1VJB SER B 226 UNP P62509 EXPRESSION TAG SEQADV 1VJB HIS B 227 UNP P62509 EXPRESSION TAG SEQADV 1VJB MET B 228 UNP P62509 EXPRESSION TAG SEQRES 1 A 251 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 251 LEU VAL PRO ARG GLY SER HIS MET PRO ALA LYS LYS PRO SEQRES 3 A 251 TYR ASN LYS ILE VAL SER HIS LEU LEU VAL ALA GLU PRO SEQRES 4 A 251 GLU LYS ILE TYR ALA MET PRO ASP PRO THR VAL PRO ASP SEQRES 5 A 251 SER ASP ILE LYS ALA LEU THR THR LEU CYS ASP LEU ALA SEQRES 6 A 251 ASP ARG GLU LEU VAL VAL ILE ILE GLY TRP ALA LYS HIS SEQRES 7 A 251 ILE PRO GLY PHE SER THR LEU SER LEU ALA ASP GLN MET SEQRES 8 A 251 SER LEU LEU GLN SER ALA TRP MET GLU ILE LEU ILE LEU SEQRES 9 A 251 GLY VAL VAL TYR ARG SER LEU SER PHE GLU ASP GLU LEU SEQRES 10 A 251 VAL TYR ALA ASP ASP TYR ILE MET ASP GLU ASP GLN SER SEQRES 11 A 251 LYS LEU ALA GLY LEU LEU ASP LEU ASN ASN ALA ILE LEU SEQRES 12 A 251 GLN LEU VAL LYS LYS TYR LYS SER MET LYS LEU GLU LYS SEQRES 13 A 251 GLU GLU PHE VAL THR LEU LYS ALA ILE ALA LEU ALA ASN SEQRES 14 A 251 SER ASP SER MET HIS ILE GLU ASP VAL GLU ALA VAL GLN SEQRES 15 A 251 LYS LEU GLN ASP VAL LEU HIS GLU ALA LEU GLN ASP TYR SEQRES 16 A 251 GLU ALA GLY GLN HIS MET GLU ASP PRO ARG ARG ALA GLY SEQRES 17 A 251 LYS MET LEU MET THR LEU PRO LEU LEU ARG GLN THR SER SEQRES 18 A 251 THR LYS ALA VAL GLN HIS PHE TYR ASN ILE LYS LEU GLU SEQRES 19 A 251 GLY LYS VAL PRO MET HIS LYS LEU PHE LEU GLU MET LEU SEQRES 20 A 251 GLU ALA LYS VAL SEQRES 1 B 251 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 251 LEU VAL PRO ARG GLY SER HIS MET PRO ALA LYS LYS PRO SEQRES 3 B 251 TYR ASN LYS ILE VAL SER HIS LEU LEU VAL ALA GLU PRO SEQRES 4 B 251 GLU LYS ILE TYR ALA MET PRO ASP PRO THR VAL PRO ASP SEQRES 5 B 251 SER ASP ILE LYS ALA LEU THR THR LEU CYS ASP LEU ALA SEQRES 6 B 251 ASP ARG GLU LEU VAL VAL ILE ILE GLY TRP ALA LYS HIS SEQRES 7 B 251 ILE PRO GLY PHE SER THR LEU SER LEU ALA ASP GLN MET SEQRES 8 B 251 SER LEU LEU GLN SER ALA TRP MET GLU ILE LEU ILE LEU SEQRES 9 B 251 GLY VAL VAL TYR ARG SER LEU SER PHE GLU ASP GLU LEU SEQRES 10 B 251 VAL TYR ALA ASP ASP TYR ILE MET ASP GLU ASP GLN SER SEQRES 11 B 251 LYS LEU ALA GLY LEU LEU ASP LEU ASN ASN ALA ILE LEU SEQRES 12 B 251 GLN LEU VAL LYS LYS TYR LYS SER MET LYS LEU GLU LYS SEQRES 13 B 251 GLU GLU PHE VAL THR LEU LYS ALA ILE ALA LEU ALA ASN SEQRES 14 B 251 SER ASP SER MET HIS ILE GLU ASP VAL GLU ALA VAL GLN SEQRES 15 B 251 LYS LEU GLN ASP VAL LEU HIS GLU ALA LEU GLN ASP TYR SEQRES 16 B 251 GLU ALA GLY GLN HIS MET GLU ASP PRO ARG ARG ALA GLY SEQRES 17 B 251 LYS MET LEU MET THR LEU PRO LEU LEU ARG GLN THR SER SEQRES 18 B 251 THR LYS ALA VAL GLN HIS PHE TYR ASN ILE LYS LEU GLU SEQRES 19 B 251 GLY LYS VAL PRO MET HIS LYS LEU PHE LEU GLU MET LEU SEQRES 20 B 251 GLU ALA LYS VAL HET OHT A 100 29 HET OHT B 200 29 HETNAM OHT 4-HYDROXYTAMOXIFEN FORMUL 3 OHT 2(C26 H29 N O2) HELIX 1 1 ASN A 235 GLU A 245 1 11 HELIX 2 2 SER A 260 LYS A 284 1 25 HELIX 3 3 SER A 293 LEU A 318 1 26 HELIX 4 4 GLU A 334 GLY A 341 1 8 HELIX 5 5 LEU A 342 MET A 359 1 18 HELIX 6 6 GLU A 362 ASN A 376 1 15 HELIX 7 7 ASP A 384 HIS A 407 1 24 HELIX 8 8 ARG A 412 THR A 420 1 9 HELIX 9 9 THR A 420 ILE A 438 1 19 HELIX 10 10 ASN B 235 GLU B 245 1 11 HELIX 11 11 SER B 260 LYS B 284 1 25 HELIX 12 12 SER B 293 SER B 317 1 25 HELIX 13 13 ASP B 333 GLY B 341 1 9 HELIX 14 14 LEU B 342 SER B 358 1 17 HELIX 15 15 GLU B 362 ASN B 376 1 15 HELIX 16 16 ASP B 384 HIS B 407 1 24 HELIX 17 17 ARG B 412 MET B 419 1 8 HELIX 18 18 THR B 420 GLU B 441 1 22 SHEET 1 A 2 GLU A 323 ALA A 327 0 SHEET 2 A 2 TYR A 330 ASP A 333 -1 O MET A 332 N LEU A 324 SHEET 1 B 2 LEU B 324 ALA B 327 0 SHEET 2 B 2 TYR B 330 MET B 332 -1 O MET B 332 N LEU B 324 SITE 1 AC1 11 LEU A 268 CYS A 269 ALA A 272 ASP A 273 SITE 2 AC1 11 GLU A 275 VAL A 313 TYR A 326 LEU A 342 SITE 3 AC1 11 LEU A 345 ALA A 431 HIS A 434 SITE 1 AC2 11 LEU A 294 LEU B 265 LEU B 268 CYS B 269 SITE 2 AC2 11 ALA B 272 ASP B 273 GLU B 275 VAL B 313 SITE 3 AC2 11 TYR B 326 ALA B 431 PHE B 435 CRYST1 74.624 74.624 144.778 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013401 0.007737 0.000000 0.00000 SCALE2 0.000000 0.015474 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006907 0.00000